Chemical Overview
Flunil 40mg is a selective serotonin reuptake inhibitor (SSRI) manufactured by Intas Pharmaceuticals for neuropharmacological research applications. This pharmaceutical-grade compound contains fluoxetine hydrochloride, a potent and selective inhibitor of serotonin reuptake mechanisms that has been extensively studied in neuroscience research for over three decades. Researchers examining serotonergic pathways and neurotransmitter function can investigate this well-characterised compound alongside other research chemicals available from our comprehensive inventory at Stroid UK Shop.
Scientific Research Context
Fluoxetine hydrochloride operates through selective inhibition of the serotonin transporter (SERT), effectively blocking reuptake of serotonin from synaptic clefts in neural tissue models. This mechanism results in increased synaptic serotonin concentrations, making it valuable for studying mood regulation pathways, synaptic plasticity, and neurotransmitter dynamics in laboratory settings. Research teams investigating depression models, anxiety mechanisms, or serotonergic system function often examine this compound alongside other neurochemical modulators. Our fluoxetine research compounds complement investigations involving selective androgen receptor modulators and peptide research tools for comprehensive neurobiological studies.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Fluoxetine Hydrochloride |
| Concentration | 40mg per unit |
| Manufacturer | Intas Pharmaceuticals |
| CAS Number | 56296-78-7 |
| Molecular Formula | C₁₇H₁₈F₃NO·HCl |
| Molecular Weight | 345.79 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Pharmaceutical standard |
Laboratory Compliance
This fluoxetine preparation is supplied strictly for in-vitro laboratory research and analytical purposes only. Flunil 40mg is not intended for human consumption, therapeutic application, or any clinical use. Research institutions and qualified laboratories should handle this compound according to established safety protocols for pharmaceutical research materials. All studies involving this compound must comply with institutional research guidelines and applicable regulations governing neuropharmacological research chemicals.
